Showing results (91-100 of 100) with videos related to
Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Journal of Cell Science|July 13, 2000
Membrane gamma-glutamyl transpeptidase activity of melanoma cells: effects on cellular H(2)O(2) production, cell surface protein thiol oxidation and NF-kappa B activation statusE Maellaro, S Dominici, B Del Bello, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
BBR 3464: a novel triplatinum complex, exhibiting a preclinical profile of antitumor efficacy different from cisplatinC Manzotti, G Pratesi, E Menta, et al.Biochemical Pharmacology|August 27, 1998
Decreased drug accumulation and increased tolerance to DNA damage in tumor cells with a low level of cisplatin resistanceC Lanzi, P Perego, R Supino, et al.British Journal of Cancer|September 2, 1999
A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenograftsG Pratesi, P Perego, D Polizzi, et al.Molecular Pharmacology|March 3, 1999
A novel trinuclear platinum complex overcomes cisplatin resistance in an osteosarcoma cell systemP Perego, C Caserini, L Gatti, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Improved efficacy and enlarged spectrum of activity of a novel anthracycline disaccharide analogue of doxorubicin against human tumor xenograftsG Pratesi, M De Cesare, C Caserini, et al.Oncogene|February 23, 2011
TIMP3 regulates migration, invasion and in vivo tumorigenicity of thyroid tumor cellsM C Anania, M Sensi, E Radaelli, et al.Biochemical Pharmacology|March 7, 2001
Configurational requirements of the sugar moiety for the pharmacological activity of anthracycline disaccharidesF Arcamone, F Animati, M Bigioni, et al.Oncology|September 28, 2001
A novel 9-aza-anthrapyrazole effective against human prostatic carcinoma xenograftsR Supino, D Polizzi, R Pavesi, et al.Journal of the National Cancer Institute|August 20, 1997
Doxorubicin disaccharide analogue: apoptosis-related improvement of efficacy in vivoF Arcamone, F Animati, M Berettoni, et al.Pageof 10